These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

550 related articles for article (PubMed ID: 16322159)

  • 21. Therapy of symptomatic patent ductus arteriosus in preterms using mefenemic acid and indomethacin.
    Sakhalkar VS; Merchant RH
    Indian Pediatr; 1992 Mar; 29(3):313-8. PubMed ID: 1612672
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Indomethacin responsiveness of patent ductus arteriosus and renal abnormalities in preterm infants treated with indomethacin.
    Itabashi K; Ohno T; Nishida H
    J Pediatr; 2003 Aug; 143(2):203-7. PubMed ID: 12970633
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The use of ibuprofen in neonates in the treatment of patent ductus arteriosus.
    Van Overmeire B
    Int J Clin Pract Suppl; 2003 Apr; (135):23-7. PubMed ID: 12723743
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Patent ductus arteriosus in premature newborns. Treatment with indomethacin (author's transl)].
    Marchal F; Monin P; Vert P; Bianchetti G; Morselli PL
    Arch Fr Pediatr; 1981; 38(7):503-8. PubMed ID: 7283656
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Indomethacin prophylaxis for patent ductus arteriosus (PDA) in infants with a birth weight of less than 1250 grams.
    Supapannachart S; Khowsathit P; Patchakapati B
    J Med Assoc Thai; 1999 Nov; 82 Suppl 1():S87-92. PubMed ID: 10730525
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effects of indomethacin tocolysis on the postnatal response of the ductus arteriosus to indomethacin in extremely low birth weight infants.
    Cordero L; Nankervis CA; Gardner D; Giannone PJ
    J Perinatol; 2007 Jan; 27(1):22-7. PubMed ID: 17053778
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Indomethacin treatment for symptomatic patent ductus arteriosus: a double-blind control study.
    Yanagi RM; Wilson A; Newfeld EA; Aziz KU; Hunt CE
    Pediatrics; 1981 May; 67(5):647-52. PubMed ID: 7019841
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative evaluation for the use of oral ibuprofen and intravenous indomethacin in Korean infants with patent ductus.
    Heo MJ; Lee OS; Lim SC
    Arch Pharm Res; 2012 Sep; 35(9):1673-83. PubMed ID: 23054725
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Management of patent ductus arteriosus in preterm infants.
    Ekici F; Atasay B; Günlemez A; Naçar N; Tutar E; Atalay S; Eyileten Z; Uysalel A; Arsan S
    Anadolu Kardiyol Derg; 2006 Mar; 6(1):28-33. PubMed ID: 16524797
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of two neonatal indomethacin protocols: efficacy and outcome for patent ductus arteriosus closure.
    Rosito G; Sum K; Chorne N
    J Clin Pharm Ther; 2010 Oct; 35(5):589-92. PubMed ID: 20831682
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacologic closure of patent ductus arteriosus in the premature infant.
    Friedman WF; Hirschklau MJ; Printz MP; Pitlick PT; Kirkpatrick SE
    N Engl J Med; 1976 Sep; 295(10):526-9. PubMed ID: 820994
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ibuprofen lysine for the prevention and treatment of patent ductus arteriosus.
    Pai VB; Sakadjian A; Puthoff TD
    Pharmacotherapy; 2008 Sep; 28(9):1162-82. PubMed ID: 18752387
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dose-finding study of ibuprofen in patent ductus arteriosus using the continual reassessment method.
    Desfrere L; Zohar S; Morville P; Brunhes A; Chevret S; Pons G; Moriette G; Rey E; Treluyer JM
    J Clin Pharm Ther; 2005 Apr; 30(2):121-32. PubMed ID: 15811164
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effectiveness and safety of indomethacin versus ibuprofen for the treatment of patent ductus arteriosus in preterm infants.
    Sivanandan S; Bali V; Soraisham AS; Harabor A; Kamaluddeen M
    Am J Perinatol; 2013 Oct; 30(9):745-50. PubMed ID: 23322388
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [New aspects in the treatment of patent ductus arteriosus in premature newborns with respiratory insufficiency].
    Weninger M; Pollak A; Salzer-Muhar U; Simbruner G; Salzer HR; Rosenkranz M
    Z Geburtshilfe Perinatol; 1989; 193(5):226-9. PubMed ID: 2815899
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Necrotizing enterocolitis and gastrointestinal complications after indomethacin therapy and surgical ligation in premature infants with patent ductus arteriosus.
    O'Donovan DJ; Baetiong A; Adams K; Chen A; Smith EO; Adams JM; Weisman LE
    J Perinatol; 2003 Jun; 23(4):286-90. PubMed ID: 12774134
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Is surgical ligation of patent ductus arteriosus necessary? The Western Australian experience of conservative management.
    Brooks JM; Travadi JN; Patole SK; Doherty DA; Simmer K
    Arch Dis Child Fetal Neonatal Ed; 2005 May; 90(3):F235-9. PubMed ID: 15846015
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effects of indomethacin on renal function and intracranial hemorrhage in infants with patent ductus arteriosus.
    Davis JM; Hendricks-Munoz KD; Hagberg D; Manning JA
    Dev Pharmacol Ther; 1990; 14(1):15-9. PubMed ID: 2311476
    [TBL] [Abstract][Full Text] [Related]  

  • 39. B-type natriuretic peptide concentrations to guide treatment of patent ductus arteriosus.
    Attridge JT; Kaufman DA; Lim DS
    Arch Dis Child Fetal Neonatal Ed; 2009 May; 94(3):F178-82. PubMed ID: 18981033
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The treatment of patent ductus arteriosus in preterm infants. A review and overview of randomized trials.
    Knight DB
    Semin Neonatol; 2001 Feb; 6(1):63-73. PubMed ID: 11162286
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.